| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
BRIEF REPORT |
Department of Radiology, Department of Surgery and Integrated Methodologies (A.T., C.M.), Department of Endocrinological and Medical Sciences and Center of Excellence for Biomedical Research (E.R., F.B., F.M., D.F.), and Department of Neurophysiology (R.N.), University of Genoa, I-16132 Genova, Italy
Address all correspondence and requests for reprints to: Diego Ferone, M.D., Ph.D., Department of Endocrine and Medical Sciences (DiSEM), University of Genova, viale Benedetto XV, 6, 16132 Genova, Italy. E-mail: ferone{at}unige.it.
| Abstract |
|---|
|
|
|---|
Objective: Our objective was to examine median (MN) and ulnar nerves (UN) of acromegalic patients with ultrasound (US) and to determine whether nerve abnormalities correlate with clinical parameters and nerve conduction studies (NCS).
Patients: We prospectively examined the MN and UN in 34 nondiabetic, acromegalic patients (18 females and 16 males; age range 18–79 yr) and 34 sex-, age-, and body mass index-matched controls with 17-5 MHz US.
Intervention: The MN was examined at the carpal tunnel (MN-Ct) and at mid-forearm (MN-f) levels; the UN at the mid-forearm (UN-f) and distal arm (UN-a). A total of 272 nerve cross-sectional areas (CSA) were recorded from both patients and controls. In addition, 22 patients underwent NCS.
Results: Nerves of acromegalic patients (MN-Ct = 16.5 ± 4.4 mm2; MN-f = 10.5 ± 2.4 mm2; UN-f = 9.5 ± 3.0 mm2; UN-a = 13.1 ± 3.7 mm2) had significantly (P < 0.0001) greater CSA compared with controls (MN-Ct = 7.4 ± 1.7 mm2; MN-f = 5.5 ± 1.4 mm2; UN-f = 5.3 ± 1.4 mm2; UN-a = 6.6 ± 1.7 mm2). NCS displayed at least one abnormality in 59% of patients. Acromegalic patients, grouped according to disease activity (14 controlled, 8 partially controlled, 12 uncontrolled), had significantly (P < 0.0001) greater CSA compared with controls. Nerve CSA were significantly greater in uncontrolled patients compared to controlled, both at MN-Ct and at UN-f levels (P < 0.01). Abnormal NCS were observed in five of seven uncontrolled patients and four of nine controlled patients. IGF-I levels, but not GH levels, were correlated with CSA (r = 0.34), whereas disease duration correlated with both nerve CSA and NCS (r = 0.33 and r = 0.31).
Conclusion: US identified a significantly increased volume of MN and UN in acromegalic patients. Peripheral nerve enlargement in acromegaly seems to be an intrinsic feature of the disease related to clinical control, disease duration, and IGF-I levels.
| Introduction |
|---|
|
|
|---|
The aim of the present study was to determine the main features of nerves in these patients observed on high-resolution ultrasound (US) and to establish whether some correlation exists between clinical and electrophysiological parameters and morphological nerve abnormalities.
| Patients and Methods |
|---|
|
|
|---|
Between January 2006 and July 2006, we prospectively examined a series of 34 consecutive patients [18 females and 16 males; age range, 18–79 yr (54.9 ± 3.20); body mass index (BMI), 25.2 ± 0.90 kg/m2; disease duration range, 1–15 yr (5.1 ± 0.85)] affected by acromegaly and a control group of healthy volunteers matched for sex, age, and BMI [18 females and 16 males; age range, 23–79 yr (41.9 ± 4.62); BMI, 25.1 ± 0.75 kg/m2]. The diagnosis of acromegaly was based on established criteria (6). No patients had diabetes mellitus or hypothyroidism. The study protocol was approved by the local ethical committee, and written informed consent was obtained from all patients and controls. At the beginning of the study, six patients had a new diagnosis and did not receive any previous treatment, 19 previously underwent transsphenoidal neurosurgery (10 of 19 were also treated with somatostatin analogs), seven underwent primary medical therapy with somatostatin analogs, and the remaining patient underwent radiotherapy and octreotide therapy. Disease activity was evaluated by GH measurement during oral glucose tolerance test (OGTT) and the basal value of IGF-I (6, 7, 8). At the time of US examination, eight patients had symptoms related to the CTS. Seven other patients had a history of carpal tunnel release. Twelve patients complained of sensory disturbances (numbness and paresthesias) in the territory of distribution of the UN. Fourteen were free of symptoms in the areas supplied by the MN and UN. For statistical analysis, on the basis of disease control, patients were subdivided into "controlled" (n = 14) and "uncontrolled" (n = 12) groups, according to the evaluation of acromegaly activity based on the lack of GH suppression during OGTT (<1 µg/liter), coupled with elevated IGF-I levels (6), and a "partially controlled" group (n = 8) when a discordance among GH after OGTT and basal IGF-I values was recorded.
US studies
US examination of the MN and UN was performed with a digital scanner (IU 22; Philips, Eindhoven, The Netherlands) equipped with a broadband (frequency band, 17-5 MHz) linear array transducer. Interpretation of the US images was based on measurement of the nerve cross-sectional area (CSA). In each study, the MN was evaluated at the proximal carpal tunnel (MN-Ct) and at the middle third of the forearm (MN-f). Then, the UN was examined in the arm (UN-a) and the forearm (UN-f). The CSA of the UN was calculated at the mid-distal arm level and at 10 cm proximally to the wrist crease. A total of 272 CSA of acromegalic patients nerves were compared with the controls. All US studies were performed by a radiologist experienced in musculoskeletal US (A.T.) to avoid interobserver variability. A second specifically trained blinded nonradiologist observer (F.B.) calculated the nerve CSA again. Interobserver agreement was good (k = 0.91).
Neurophysiological examination
In 22 of 34 patients, electrophysiological nerve conduction studies (NCS) of motor and sensory function of the MN and UN were performed bilaterally. Values of the distal motor and sensory latencies, motor and sensory nerve conduction velocities, and amplitude of evoked potentials were adjusted according to the patients age, and the nerve was examined as described elsewhere (9). NCS severity was evaluated according to the existing classifications (10).
Laboratory assays
Serum GH levels were determined by means of an immunochemiluminometric assay, and IGF-I was measured by a RIA using immunochemicals and tracer provided by Biosource (Nivelles, Belgium) previously reported (11). IGF-I was measured in basal conditions, and it was reported as age-based SD scores, calculated on the basis of data obtained from over 4000 normal subjects of both sexes from 0 to 100 yr of age, grouped into decades of age.
Statistical analysis
Statistical analysis was performed using the Mann-Whitney U test for unpaired data to compare patients and controls, as well as patient groups. Values were expressed as mean ± SD. P values < 0.05 were considered statistically significant. To correlate nerve CSA with other parameters, the Pearsons test and linear regression analysis were used.
| Results |
|---|
|
|
|---|
|
|
|
Comparison between controlled and uncontrolled patients revealed significantly greater CSA in uncontrolled patients for the MN-Ct and the UN-a (P < 0.01). Similarly, uncontrolled patients had significantly greater CSA than partially controlled patients at the same sites as above (P < 0.02). No difference between partially controlled and controlled patients was observed (results summarized in Table 1
).
Neurophysiological studies
At electrophysiology, 13 of 22 (59%) reported at least one abnormal finding. No statistical correlation was observed between nerve CSA and electrophysiological data. NCS were abnormal in five of seven uncontrolled, four of nine controlled, and four of eight partially controlled patients.
| Discussion |
|---|
|
|
|---|
We studied nerves in patients with acromegaly using high-resolution US to assess the possible value of imaging in this heterogeneous and clinically challenging group. US allowed an accurate and reliable depiction of both MN and UN based on established criteria (16). On short-axis planes, nerves exhibited a well-defined honeycombing appearance made of multiple rounded hypoechoic fascicles embedded in the hyperechoic epineurium (Fig. 1
). Whatever the sampling site and the nerve examined, nerves of acromegalic patients showed a significantly larger CSA compared with corresponding nerves of the control group. The nerve enlargement was diffuse throughout the upper extremity, indicating a disease-related process that was basically unrelated to entrapment syndromes. In addition, the fascicular echotexture was always preserved, a figure that may be lost in focal neuropathies. Among other peripheral neuropathies, the Charcot-Marie-Tooth syndrome is the only disorder presenting with US changes somewhat resembling those observed in acromegalic nerves, including diffuse multifocal nerve enlargement and preserved nerve echotexture (17). Other neuropathies, such as compressive syndromes, leprosy, fibrolipomatous hamartoma, hereditary neuropathy with liability to pressure palsy, stretching injuries, and lymphoma, may cause nerve swelling, but they typically involve one nerve only, in a more localized form and with loss of the fascicular echotexture (18, 19). In regard to quantitative measurements, the CSA of the MN at the carpal tunnel level in acromegalic patients exceeded the threshold value established for CTS in 91% of cases (12). Of these patients, 41% did not show clear clinical symptoms suggesting CTS. In patients with recognized disease, sonologists should therefore be advised not to consider the CSA of the MN over 10 mm2 as a sign of nerve compression at the carpal tunnel. Otherwise, an overestimation of CTS prevalence in acromegaly may occur with this technique. Based on our series, the characteristics of nerve enlargement in acromegaly seem to reflect a specific disease-related process rather than the result of a compressive neuropathy. This is related to the fact that nerves appeared uniformly swollen outside osteofibrous tunnels and far from the sites at which they may undergo compression. At least for the carpal tunnel, a recent work based on four acromegalic patients with symptoms of median neuropathy stated that the predominant abnormality of median neuropathy in acromegaly is endoneural edema (3). It should be considered, however, that edema depicted as an increased signal intensity on T2-weighted magnetic resonance imaging sequences is also encountered in nonacromegalic patients with CTS (20). At least in part, intraneural edema should be causative of nerve enlargement, but it seems more likely to be a factor associated with axonal loss in a variety of pathological conditions, including entrapment syndromes, traumatic injuries, and infectious disease, rather than a specific indicator of acromegaly-related neuropathy (19). When we attempted to match the nerve CSA with electrophysiological parameters, we did not find any statistically significant correlation. Such a lack of correlation was, however, observed in other neuropathies, like compressive neuropathies (19) and the Charcot-Marie-Tooth syndrome (9). These data could reinforce the general opinion that the NCS parameters used to assess the nerve function are weakly linked to morphological changes. Correlation between clinical parameters and nerve CSA suggests that nerve size may be influenced by disease duration. In regard to hormone imbalance, our study reported a positive correlation between nerve CSA or NCS and IGF-I, but not with GH values. A significantly larger CSA and more severe NCS abnormalities were detected in uncontrolled patients at the carpal tunnel and at the UN-a when compared with controlled patients. These data suggest that nerves could be directly influenced by disease activity because morphological alterations are more obvious in patients with higher hormone levels.
In conclusion, our study suggests that nerves of acromegalic patients are significantly enlarged when compared with those of normal subjects. This finding seems to represent an intrinsic feature of the disease that is related to clinical control, disease duration, and IGF-I levels. Sonologists should become familiar with these abnormalities to avoid false positives of CTS when examining acromegalic patients. In addition, care should be taken if a diffuse enlargement of more than one nerve throughout the limbs and extremities without abnormalities in the fascicular echotexture is found. The possible occurrence of an acromegalic patient with unrecognized disease should be considered in the differential diagnosis list.
| Acknowledgments |
|---|
| Footnotes |
|---|
Disclosure Statement: A.T., E.R., R.N., F.B., F.M., D.F., and C.M. have nothing to declare.
First Published Online December 11, 2007
Abbreviations: BMI, Body mass index; CSA, cross-sectional area(s); CTS, carpal tunnel syndrome; MN, median nerve(s); MN-Ct, MN at carpal tunnel; MN-f, MN at mid-forearm; NCS, nerve conduction study (or studies); OGTT, oral glucose tolerance test; UN, ulnar nerve; UN-f, UN at mid-forearm; UN-a, UN at distal arm; US, ultrasound.
Received August 2, 2007.
Accepted December 4, 2007.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Tagliafico, E. Resmini, M. T. van Holsbeeck, L. E. Derchi, D. Ferone, and C. Martinoli Sonographic Depiction of Trigger Fingers in Acromegaly J. Ultrasound Med., November 1, 2009; 28(11): 1441 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tagliafico, E. Resmini, R. Nizzo, L. E Derchi, F. Minuto, M. Giusti, C. Martinoli, and D. Ferone The pathology of the ulnar nerve in acromegaly Eur. J. Endocrinol., October 1, 2008; 159(4): 369 - 373. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |